A BioHealth research program selected by the French Ministry of Research and Education in the framework of the "Laboratoires d'Excellence" initiative.
EpiGenMed wants to foster the best BioHealth basic and clinical research and to encourage interdisciplinary projects. The EpiGenMed project was selected by the French Ministry of Research and Education in the framework of the national "Investments for the Future" program in 2011. The project received 12 million euros in funding for a 10-year period, essentially devoted to science training through the recruitment of PhD students, post-doctoral fellows and Chairs of Excellence.
EpiGenMed involves 58 of the best research groups in Montpellier, implicated in five areas of research that cover Genome and Epigenome Dynamics, Cell cycle, Cell fate and Development, Infectious diseases and Immunology, Cell signalling and Neurobiology, Biophysics and Systems biology. It is hosted by the University of Montpellier and national science institutions and benefits from an excellent industrial environment
Workshop in Epigenetics 2019
Workshop in Epigenetics
November 12 - 19, 2019
Asifa AKHTAR - Max Planck Institute of Immunobiology and Epigenetics - Germany
Marcelo NOLLMANN - Centre de Biochimie Structurale - France
Jérôme DEJARDIN - Institut de Génétique Humaine - France
Juanma VAQUERIZAS - Max Planck Institute for Molecular Biomedicine - Germany
Lourdes PRIETO - Lilly Pharmaceuticals - Spain
Click here for the detailed program!
Postdoctoral Program 2019
The Labex (Laboratory of Excellence) EpiGenMed is a Health Sciences interdisciplinary collaborative research program at the University of Montpellier that involves 58 leading research laboratories in 14 scientific institutes in the area.
Five major axes of research are supported by this initiative:
• Genome and Epigenome
• Cell Cycle, Cell Fate and Development
• Infection and immunity
• Integrating Systems in Neuroscience
• Biophysics and Systems Biology
The EpiGenMed post-doctoral program 2019 offers several fellowships for a period of 2 years (1 year renewable).
The EpiGenMed research group leaders will select their candidate who has to be validated by the Labex EpiGenMed Scientific Committee.
Applications should be send directly to the following team leaders.